Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Total Liabilities: 2017-2018

Historic Total Liabilities for Astria Therapeutics (ATXS) over the last 2 years, with Dec 2018 value amounting to $4.2 million.

  • Astria Therapeutics' Total Liabilities rose 33.04% to $5.6 million in Q3 2019 from the same period last year, while for Sep 2019 it was $5.6 million, marking a year-over-year increase of 33.04%. This contributed to the annual value of $4.2 million for FY2018, which is 30.76% down from last year.
  • Latest data reveals that Astria Therapeutics reported Total Liabilities of $4.2 million as of FY2018, which was down 30.76% from $6.1 million recorded in FY2017.
  • In the past 5 years, Astria Therapeutics' Total Liabilities ranged from a high of $6.1 million in FY2017 and a low of $4.2 million during FY2018.
  • For the 2-year period, Astria Therapeutics' Total Liabilities averaged around $5.2 million, with its median value being $5.2 million (2017).
  • Data for Astria Therapeutics' Total Liabilities shows a maximum YoY slumped of 30.76% (in 2018) over the last 5 years.
  • Over the past 2 years, Astria Therapeutics' Total Liabilities (Yearly) stood at $6.1 million in 2017, then slumped by 30.76% to $4.2 million in 2018.